penicillin v and sulbactam

penicillin v has been researched along with sulbactam in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Chanteperdrix, V; Croizé, J; Nordmann, P; Poirel, L; Potron, A1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Aslam, H; Brewitz, L; Lukacik, P; Malla, TR; Mikolajek, H; Muntean, DG; Owen, CD; Salah, E; Schofield, CJ; Strain-Damerell, C; Tumber, A; Walsh, MA1
Aronoff, SC; Blumer, JL; Jaffe, AC; Klinger, JD; O'Brien, CA1
Bian, L; Feng, X; Li, S; Qiao, P; Zhang, Y1
Bian, L; Feng, X; Li, S; Qiao, P; Shi, P; Zhang, Y1

Trials

1 trial(s) available for penicillin v and sulbactam

ArticleYear
A double-blinded comparative study of sultamicillin and potassium penicillin V in the treatment of childhood streptococcal pharyngitis.
    The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:3

    Topics: Adolescent; Ampicillin; Child; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Female; Humans; Male; Penicillanic Acid; Penicillin V; Pharyngitis; Random Allocation; Streptococcal Infections; Streptococcus pyogenes; Sulbactam

1984

Other Studies

6 other study(ies) available for penicillin v and sulbactam

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Genetic and biochemical characterization of the first extended-spectrum CARB-type beta-lactamase, RTG-4, from Acinetobacter baumannii.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:7

    Topics: Acinetobacter baumannii; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine.
    Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11

    Topics: Antiviral Agents; beta-Lactams; Coronavirus 3C Proteases; COVID-19 Drug Treatment; Cysteine; Cysteine Endopeptidases; Humans; Penicillins; Protease Inhibitors; SARS-CoV-2

2022
Molecular recognition and binding of beta-lactamase II from Bacillus cereus with penicillin V and sulbactam by spectroscopic analysis in combination with docking simulation.
    Luminescence : the journal of biological and chemical luminescence, 2017, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; Bacillus cereus; Bacterial Proteins; Cephalosporinase; Molecular Docking Simulation; Penicillin V; Spectrum Analysis; Sulbactam

2017
Spectroscopy analysis and molecular dynamics studies on the binding of penicillin V and sulbactam to beta-lactamase II from Bacillus cereus.
    Journal of pharmaceutical and biomedical analysis, 2017, May-10, Volume: 138

    Topics: Bacillus cereus; Binding Sites; Cephalosporinase; Molecular Dynamics Simulation; Penicillin V; Protein Binding; Protein Conformation, beta-Strand; Spectrum Analysis; Static Electricity; Sulbactam

2017